Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Last Updated: December 14, 2018; Last Reviewed: December 14, 2018
|Abrams, Elaine J.||M||None||N/A|
|Best, Brookie M.||M||PPD||DSMB
|C&R Research, Inc.||DSMB|
|Cohn, Susan E.
||M||Eli Lilly and Company
|AIDS Malignancy Consortium||DSMB|
|Feinberg, Judith||M||Gilead||Research Support|
|Flynn, Patricia M.||M||Merck
||Safety Monitoring Committee|
|Kourtis, Athena, P.||HHS||None||N/A|
|Lazenby, Gweneth B.
|Maupin, Robert T.
|Mofenson, Lynne M.
|Prioleau, Fatima Y.||M||None||N/A|
|Siberry, George K.||M||None||N/A|
|Spector, Stephen A.||M||None||N/A|
|Eli Lilly and Company||Stockholder|
|Watts, D. Heather||HHS||None||N/A|
|Key to Acronyms: DSMB = Data Safety Monitoring Board; CC = Panel Co-Chairs; ES = Executive Secretary; ExOM = Ex Officio Member; HHS = Member from Department of Health and Human Services; M = Member; N/A = Not applicable; NVO = Nonvoting Observer|
- AIDSinfo Drug Database
- AIDSinfo Patient Materials: Preventing Mother-to-Child Transmission of HIV
- AIDSinfo Patient Materials: HIV Medicines During Pregnancy and Childbirth
- AIDSinfo Patient Materials: Protecting Baby from HIV
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Perinatal Guidelines Archive